Forgent Power Solutions enters July with a notable split in the data: short sellers added aggressively to positions last week while every analyst covering the stock is pointing targets higher.
The most striking development is the speed of short-side accumulation. Short interest climbed 27% over the past seven days, reaching roughly 7.3 million shares by June 30. That follows a sharp drop in late May — shares short were running above 12 million in the final week of May before collapsing to the low 5 millions through most of June, making the current rebound in positioning all the more conspicuous. The week's daily builds were consistent rather than concentrated on a single session, suggesting a deliberate rebuild rather than a forced unwind. Float data is absent from the snapshot, so precise SI % of free float cannot be calculated, but the 30-day FINRA reading of 6.7 million shares with a 1-day days-to-cover implies the short book is meaningful relative to daily trading volume.
The lending market does not corroborate a squeeze setup, however. Availability is ample at 325%, meaning roughly three shares remain available to borrow for every one already out on loan — well inside the normal range, and a long way from any kind of supply constraint. Borrowing costs confirm the same picture: the cost to borrow is a negligible 0.43%, actually down 16% on the week, and has been range-bound between 0.10% and 0.67% all month. Options are incrementally more guarded. The put/call ratio has drifted to 0.64, about one standard deviation above its 20-day average of 0.53, and has been creeping higher since bottoming near 0.32 in early June. That is more cautious than recent norms, but nowhere near the 52-week peak of 1.12. The ORTEX short score ticked up to 45.8 from 41.5 two weeks ago — rising, but well short of territory that would signal elevated squeeze or crowded-short risk. Together, the positioning picture reads as shorts building into modest borrow, not a high-conviction panic setup.
The analyst community is pulling in the opposite direction. All six covering analysts carry buy-equivalent ratings, and the post-May earnings wave of target increases was broad-based — Goldman Sachs, Oppenheimer, Keybanc, and Barclays all raised targets in mid-May following results, with targets moving from the low $40s to the $55-$60 range. The most recent action came last week: TD Cowen lifted its target to $73 from $63, the highest on the Street, while maintaining its Buy rating. Morgan Stanley is the lone holdout at Equal-Weight, with a $51 target — below the current price of $55.86 — but even Morgan Stanley raised its target from $38 after the May print. The consensus mean sits at $58.75, implying about 5% upside from current levels, which is modest but directionally positive. Valuation has re-rated alongside: the trailing P/E has expanded roughly 18 points over 30 days to 64.6x, and the price-to-book has risen about 5 points to 29.5x — premium multiples that reflect strong earnings-per-share momentum and the company's positioning in grid infrastructure.
The ownership structure adds an important overlay. Neos Partners LP held 45% of shares as of June 1, but disclosed a sale of 48.6 million shares on that date at $45.71 per share — a transaction worth roughly $2.2 billion. That follows a 34.5-million-share sale by the same sponsor in late March. The three insider transactions filed over the past 90 days are all sponsor sell-downs, totalling approximately $3.2 billion in proceeds. Neos still holds roughly 110 million shares even after these disposals, so the overhang has not been cleared. BlackRock's addition of 5.1 million shares (a new position) alongside fresh Vanguard and Schwab entries suggests institutional buyers have been absorbing at least part of the sponsor supply — but the cadence of further distributions from Neos remains the single largest structural question hanging over the stock.
The stock closed at $55.86, up 1.6% on Tuesday but down 5.8% on the week, with the earnings history showing a brief 1% dip after the May release followed by a 6.6% five-day recovery — and a more significant 16% gap higher after the March print. No next earnings date is scheduled in the data. The convergence of an accelerating short rebuild, a still-generous analyst consensus, and an active sponsor overhang makes the pace and pricing of any further Neos distribution the factor worth watching most closely from here.
See the live data behind this article on ORTEX.
Open FPS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
